1. Cardiology Unit, Department of Medicine Solna, Karolinska Institute & Karolinska University Hospital, Stockholm, Sweden
2. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomedica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Barcelona, Spain
3. Department of Cardiovascular and Metabolic Diseases, IRCCS MultiMedica, Sesto San Giovanni, Italy
4. Novo Nordisk A/S, Søborg, Denmark
5. Department of Medicine, University of Padova, Padova, Italy
6. Baylor College of Medicine, Houston, Texas, USA
7. Campbell University College of Pharmacy and Health Sciences, Cary, North Carolina, USA
8. Boehringer Ingelheim International, Pharma GmbH & Co. KG, Ingelheim, Germany
9. Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK
10. Diabetes Research Centre, Leicester, UK
11. AstraZeneca, Gothenburg, Sweden
12. Brigham and Women’s Hospital, Boston, Massachusetts, USA
13. Department of Medicine, K2, Karolinska Institute, Stockholm, Sweden
14. Division of Diabetes, Nutrition, and Metabolic Disorders, Division of Clinical Pharmacology, CHU de Liège, University of Liège, Liège, Belgium
15. Forschergruppe Diabetes eV at Munich Helmholtz Centre, Munich, Germany
16. Department of Public Health, University of Helsinki, Helsinki, Finland
17. Chronic Disease Prevention Unit, National Institute for Health and Welfare, Helsinki, Finland
18. Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia
19. Inserm, Centre d’Investigations Cliniques- 1433, and Inserm U1116, CHRU, Nancy, France
20. Université de Lorraine, Nancy, France
21. F-CRIN INI-CRCT, Nancy, France